| 1 |
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
Jedd D. Wolchok, Bart Neyns, Gerald P. Linette et al. · The Lancet Oncology
|
9 Dec 2009 |
1,198 |
| 2 |
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Kenneth I. Ataga, Abdullah Kutlar, Julie Kanter et al. · New England Journal of Medicine
Open access |
3 Dec 2016 |
908 |
| 3 |
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
David J. Kuter et al. · The Lancet
|
Feb 2008 |
872 |
| 4 |
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
Carolyn D. Runowicz, Corinne R. Leach, N. Lynn Henry et al. · CA A Cancer Journal for Clinicians
Open access |
7 Dec 2015 |
752 |
| 5 |
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
William D. Tap, Robin L. Jones, Brian Andrew Van Tine et al. · The Lancet
Open access |
12 Jun 2016 |
595 |
| 6 |
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer
Jeffrey D. Bradley, Chen Hu, Ritsuko R. Komaki et al. · Journal of Clinical Oncology
Open access |
16 Dec 2019 |
594 |
| 7 |
Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer
Bernard Fisher, James J. Dignam, Birol Emir et al. · JNCI Journal of the National Cancer Institute
|
19 Nov 1997 |
527 |
| 8 |
Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules
Morad K. Nakhleh et al. · ACS Nano
Open access |
21 Dec 2016 |
507 |
| 9 |
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Petros D. Grivas et al. · Annals of Oncology
Open access128 authors |
19 Mar 2021 |
327 |
| 10 |
Rural–Urban Disparities in Cancer Outcomes: Opportunities for Future Research
Smita Bhatia, Wendy Landier, Electra D. Paskett et al. · JNCI Journal of the National Cancer Institute
Open access |
4 Feb 2022 |
324 |
| 11 |
National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
Bronwen E. Shaw et al. · Journal of Clinical Oncology
Open access |
27 Apr 2021 |
221 |
| 12 |
Silicon Nanowire Sensors Enable Diagnosis of Patients via Exhaled Breath
Nisreen Shehada, John C. Cancilla, José S. Torrecilla et al. · ACS Nano
|
6 Jul 2016 |
221 |
| 13 |
Leukocytosis: basics of clinical assessment.
Neil Remington Abramson, Becky Melton · PubMed
|
Nov 2000 |
215 |
| 14 |
Benign Metastasizing Leiomyoma
Simeon Abramson, Robert Gilkeson, Jeffrey D. Goldstein et al. · American Journal of Roentgenology
|
Jun 2001 |
193 |
| 15 |
Quality of Life Analysis of a Radiation Dose–Escalation Study of Patients With Non–Small-Cell Lung Cancer
Benjamin Movsas, Chen Hu, Jeffrey A. Sloan et al. · JAMA Oncology
Open access |
25 Nov 2015 |
183 |
| 16 |
Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: The Memphis experience
Kevin Thomas Robbins, Parvesh Kumar, William F. Regine et al. · International Journal of Radiation Oncology*Biology*Physics
|
May 1997 |
168 |
| 17 |
Three-dimensional treatment planning of intracavitary gynecologic implants: Analysis of ten cases and implications for dose specification
Sonja L. Schoeppel, Mark L. Lavigne, Mary K. Martel et al. · International Journal of Radiation Oncology*Biology*Physics
Open access |
1994 |
159 |
| 18 |
Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials
Joseph M. Unger, Anna B. Moseley, Christabel K. Cheung et al. · Journal of Clinical Oncology
Open access |
17 Mar 2021 |
151 |
| 19 |
Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer
Raymond Uyiosa Osarogiagbon, Obiageli Uchenna Ogbata, Xinhua Yu · The Annals of Thoracic Surgery
Open access |
21 Nov 2013 |
139 |
| 20 |
The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies
Benjamin Movsas, Charles Scott, William T. Sause et al. · International Journal of Radiation Oncology*Biology*Physics
|
Dec 1999 |
126 |
| 21 |
Risk Factors for Ischemic Complications following Pipeline Embolization Device Treatment of Intracranial Aneurysms: Results from the IntrePED Study
Waleed Brinjikji, Giuseppe S Lanzino, Harry J. Cloft et al. · American Journal of Neuroradiology
Open access |
21 Apr 2016 |
123 |
| 22 |
Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: Results of two randomized double blind controlled multiinstitutional trials
Aman U. Buzdar, Robert A. Smith, Charles L. Vogel et al. · Cancer
|
15 Jun 1996 |
119 |
| 23 |
Prospective study on embolization of intracranial aneurysms with the pipeline device (PREMIER study): 3-year results with the application of a flow diverter specific occlusion classification
Ricardó A. Hanel et al. · Journal of NeuroInterventional Surgery
Open access |
15 Mar 2022 |
105 |
| 24 |
Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database
Yolanda D. Tseng, Hajime Uno, Melissa E. Hughes et al. · International Journal of Radiation Oncology*Biology*Physics
|
11 Jul 2015 |
99 |
| 25 |
Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma
Martin M. Oken, David P. Harrington, Neil Remington Abramson et al. · Cancer
|
15 Apr 1997 |
98 |
| 26 |
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
Ulrich Keilholz, Janice M. Mehnert, Sebastian Bauer et al. · Journal for ImmunoTherapy of Cancer
Open access |
16 Jan 2019 |
82 |
| 27 |
Pretreatment18F-FDG PET Textural Features in Locally Advanced Non–Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235
Nitin Ohri, Fenghai Duan, Bradley S. Snyder et al. · Journal of Nuclear Medicine
Open access |
11 Feb 2016 |
81 |
| 28 |
American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism
Mark Zafereo, Justin Yu, Peter Angelos et al. · Head & Neck
|
19 Apr 2019 |
80 |
| 29 |
Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer
Stephen C. Lam, Chunxue Bai, David R. Baldwin et al. · Journal of Thoracic Oncology
Open access |
23 Jul 2023 |
78 |
| 30 |
Anesthesia Duration as an Independent Risk Factor for Postoperative Complications in Free Flap Surgery: A Review of 1,305 Surgical Cases
David J.W. Grant, Bobby Kim, Jon Ver Halen et al. · Journal of Reconstructive Microsurgery
|
25 Oct 2013 |
78 |
| 31 |
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Johannes Duell, Philip Edward Lammers, Ivana M. Djuretic et al. · Clinical Pharmacology & Therapeutics
Open access |
16 Feb 2019 |
77 |
| 32 |
Pretreatment FDG-PET Metrics in Stage III Non-Small Cell Lung Cancer: ACRIN 6668/RTOG 0235
Nisha Ohri, Fenghai Duan, Mitchell X. Machtay et al. · JNCI Journal of the National Cancer Institute
Open access |
16 Feb 2015 |
76 |
| 33 |
Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database
Mark W. Onaitis, Anthony P. Furnary, Andrzej Stanislaw Kosinski et al. · The Annals of Thoracic Surgery
|
22 Nov 2017 |
70 |
| 34 |
Differential effects of operative complications on survival after surgery for primary lung cancer
Félix G. Fernández, Andrzej Stanislaw Kosinski, Anthony P. Furnary et al. · Journal of Thoracic and Cardiovascular Surgery
Open access |
13 Nov 2017 |
70 |
| 35 |
Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer
Lisa Ann Kachnic, Kathryn A Winter, Robert J. Myerson et al. · International Journal of Radiation Oncology*Biology*Physics
Open access |
13 Aug 2021 |
65 |
| 36 |
Management of pterygium with surgery and radiation therapy
Shyam B. Paryani, Walter P. Scott, JOHN W. WELLS et al. · International Journal of Radiation Oncology*Biology*Physics
Open access |
1994 |
64 |
| 37 |
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer
Matthew P. Smeltzer, Nicholas Ryan Faris, Xinhua Yu et al. · The Annals of Thoracic Surgery
Open access |
3 Jun 2016 |
63 |
| 38 |
Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group 9513
Barbara C. Fisher, Minhee Won, David Robert Walker MacDonald et al. · International Journal of Radiation Oncology*Biology*Physics
|
Jul 2002 |
62 |
| 39 |
Impact of Guideline Changes on Use or Omission of Radiation in the Elderly with Early Breast Cancer: Practice Patterns at National Comprehensive Cancer Network Institutions
Beryl L. McCormick, Rebecca A. Ottesen, Melissa E. Hughes et al. · Journal of the American College of Surgeons
|
7 Jun 2014 |
62 |
| 40 |
Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma
Asim Amin, David H. Lawson, April K.S. Salama et al. · Journal for ImmunoTherapy of Cancer
Open access |
22 Jul 2016 |
61 |
| 41 |
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)
Kenneth L. Kehl, David M. Zahrieh, Ping Yang et al. · JAMA Oncology
Open access |
17 Mar 2022 |
57 |
| 42 |
Assessing Safety and Outcomes in Outpatient versus Inpatient Thyroidectomy using the NSQIP: A Propensity Score Matched Analysis of 16,370 Patients
Nima Khavanin, Alexei S. Mlodinow, John Y. S. Kim et al. · Annals of Surgical Oncology
|
19 May 2014 |
57 |
| 43 |
Platelet Testing is Associated with Worse Clinical Outcomes for Patients Treated with the Pipeline Embolization Device
Waleed Brinjikji, Giuseppe S Lanzino, Harry J. Cloft et al. · American Journal of Neuroradiology
Open access |
6 Aug 2015 |
57 |
| 44 |
Mastering Communication with Seriously Ill Patients: Balancing Honesty with Empathy and Hope
Neil Remington Abramson · Annals of Internal Medicine
|
3 Nov 2009 |
56 |
| 45 |
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial
Bronwen E. Shaw et al. · Transplantation and Cellular Therapy
Open access |
27 Dec 2022 |
55 |
| 46 |
Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer
Mark W. Onaitis, Anthony P. Furnary, Andrzej Stanislaw Kosinski et al. · The Annals of Thoracic Surgery
|
29 Feb 2020 |
54 |
| 47 |
Angioplasty and stenting for symptomatic extracranial non-tandem internal carotid artery occlusion
Ashutosh Prabhakar Jadhav, David Michael Panczykowski, Mouhammad A. Jumaa et al. · Journal of NeuroInterventional Surgery
|
29 Apr 2018 |
53 |
| 48 |
Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists
Kathryn Finch Mileham, Caroline Schenkel, Suanna S. Bruinooge et al. · Cancer Medicine
Open access |
17 Dec 2021 |
52 |
| 49 |
Variations in Receipt of Curative-Intent Surgery for Early-Stage Non–Small Cell Lung Cancer (NSCLC) by State
Helmneh M. Sineshaw, Xiao‐Cheng Wu, W. Dana Flanders et al. · Journal of Thoracic Oncology
Open access |
12 Mar 2016 |
51 |
| 50 |
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials
Renata Ferrarotto, Ian C. Anderson, Balazs Medgyasszay et al. · Cancer Medicine
Open access |
18 Aug 2021 |
50 |